Literature DB >> 9605480

Alteration of myo-inositol monophosphatase in Alzheimer's disease brains.

S Shimohama1, H Tanino, Y Sumida, J Tsuda, S Fujimoto.   

Abstract

myo-Inositol monophosphatase (E.C.3.1.3.25) catalyzes the hydrolysis of myo-inositol 1-phosphate in the presence of Mg2+ at a physiologic pH to form free myo-inositol, maintaining a supply that represents the precursor for inositol phospholipid second messenger signaling systems. In the present study the activity and protein level of myo-inositol monophosphatase were investigated in samples from normal human and Alzheimer's disease (AD) postmortem brains. The separation profile on Sephadex G-100 gel filtration chromatography revealed one major form of myo-inositol monophosphatase in crude extracts from both normal human and AD brains. In AD brains myo-inositol monophosphatase activity and its protein level were significantly higher than in control brains. The activity of myo-inositol monophosphatase per enzyme molecule was similar in control and AD brains. These results suggest that myo-inositol monophosphatase is upregulated in AD, probably reflecting compensatory mechanisms concerned with phospholipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605480     DOI: 10.1016/s0304-3940(98)00209-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Phosphorylation regulates myo-inositol-3-phosphate synthase: a novel regulatory mechanism of inositol biosynthesis.

Authors:  Rania M Deranieh; Quan He; Joseph A Caruso; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2013-07-30       Impact factor: 5.157

2.  Identification of myo-inositol-3-phosphate synthase isoforms: characterization, expression, and putative role of a 16-kDa gamma(c) isoform.

Authors:  Ratnam S Seelan; Jaganathan Lakshmanan; Manuel F Casanova; Ranga N Parthasarathy
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

3.  Identifying unexpected therapeutic targets via chemical-protein interactome.

Authors:  Lun Yang; Jian Chen; Leming Shi; Michael P Hudock; Kejian Wang; Lin He
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

4.  Perturbation of the Vacuolar ATPase: A NOVEL CONSEQUENCE OF INOSITOL DEPLETION.

Authors:  Rania M Deranieh; Yihui Shi; Maureen Tarsio; Yan Chen; J Michael McCaffery; Patricia M Kane; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

5.  Lavandula angustifolia Effects on Rat Models of Alzheimer's Disease Through the Investigation of Serum Metabolic Features Using NMR Metabolomics.

Authors:  Afsaneh Arefi Oskouie; Reyhaneh Farrokhi Yekta; Mostafa Rezaei Tavirani; Masoud Soheili Kashani; Fatemeh Goshadrou
Journal:  Avicenna J Med Biotechnol       Date:  2018 Apr-Jun

6.  Genome-wide analysis of Saccharomyces cerevisiae identifies cellular processes affecting intracellular aggregation of Alzheimer's amyloid-β42: importance of lipid homeostasis.

Authors:  S Nair; M Traini; I W Dawes; G G Perrone
Journal:  Mol Biol Cell       Date:  2014-05-28       Impact factor: 4.138

7.  The Inositol-3-Phosphate Synthase Biosynthetic Enzyme Has Distinct Catalytic and Metabolic Roles.

Authors:  Anna D Frej; Jonathan Clark; Caroline I Le Roy; Sergio Lilla; Peter A Thomason; Grant P Otto; Grant Churchill; Robert H Insall; Sandrine P Claus; Phillip Hawkins; Len Stephens; Robin S B Williams
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.